508 related articles for article (PubMed ID: 16101513)
1. Altering the tropism of lentiviral vectors through pseudotyping.
Cronin J; Zhang XY; Reiser J
Curr Gene Ther; 2005 Aug; 5(4):387-98. PubMed ID: 16101513
[TBL] [Abstract][Full Text] [Related]
2. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.
Beyer WR; Westphal M; Ostertag W; von Laer D
J Virol; 2002 Feb; 76(3):1488-95. PubMed ID: 11773421
[TBL] [Abstract][Full Text] [Related]
3. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.
Zhang XY; La Russa VF; Reiser J
J Virol; 2004 Feb; 78(3):1219-29. PubMed ID: 14722277
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.
Kahl CA; Marsh J; Fyffe J; Sanders DA; Cornetta K
J Virol; 2004 Feb; 78(3):1421-30. PubMed ID: 14722297
[TBL] [Abstract][Full Text] [Related]
5. Pseudotyped Lentiviral Vectors: One Vector, Many Guises.
Joglekar AV; Sandoval S
Hum Gene Ther Methods; 2017 Dec; 28(6):291-301. PubMed ID: 28870117
[TBL] [Abstract][Full Text] [Related]
6. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
Bartz SR; Vodicka MA
Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
[TBL] [Abstract][Full Text] [Related]
7. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
8. Generation of High-Titer Pseudotyped Lentiviral Vectors.
Hu S; Li M; Akkina R
Methods Mol Biol; 2019; 1937():125-134. PubMed ID: 30706393
[TBL] [Abstract][Full Text] [Related]
9. Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.
Desmaris N; Bosch A; Salaün C; Petit C; Prévost MC; Tordo N; Perrin P; Schwartz O; de Rocquigny H; Heard JM
Mol Ther; 2001 Aug; 4(2):149-56. PubMed ID: 11482987
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy.
Gutierrez-Guerrero A; Cosset FL; Verhoeyen E
Viruses; 2020 Sep; 12(9):. PubMed ID: 32933033
[TBL] [Abstract][Full Text] [Related]
11. Stability of Retroviral Vectors Against Ultracentrifugation Is Determined by the Viral Internal Core and Envelope Proteins Used for Pseudotyping.
Kim SH; Lim KI
Mol Cells; 2017 May; 40(5):339-345. PubMed ID: 28535668
[TBL] [Abstract][Full Text] [Related]
12. Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein.
Carpentier DC; Vevis K; Trabalza A; Georgiadis C; Ellison SM; Asfahani RI; Mazarakis ND
Gene Ther; 2012 Jul; 19(7):761-74. PubMed ID: 21900965
[TBL] [Abstract][Full Text] [Related]
13. Retargeting vesicular stomatitis virus glycoprotein pseudotyped lentiviral vectors with enhanced stability by in situ synthesized polymer shell.
Liang M; Yan M; Lu Y; Chen IS
Hum Gene Ther Methods; 2013 Feb; 24(1):11-8. PubMed ID: 23327104
[TBL] [Abstract][Full Text] [Related]
14. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.
Watson DJ; Kobinger GP; Passini MA; Wilson JM; Wolfe JH
Mol Ther; 2002 May; 5(5 Pt 1):528-37. PubMed ID: 11991743
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.
Sandrin V; Boson B; Salmon P; Gay W; Nègre D; Le Grand R; Trono D; Cosset FL
Blood; 2002 Aug; 100(3):823-32. PubMed ID: 12130492
[TBL] [Abstract][Full Text] [Related]
16. Selective transduction of astrocytic and neuronal CNS subpopulations by lentiviral vectors pseudotyped with Chikungunya virus envelope.
Eleftheriadou I; Dieringer M; Poh XY; Sanchez-Garrido J; Gao Y; Sgourou A; Simmons LE; Mazarakis ND
Biomaterials; 2017 Apr; 123():1-14. PubMed ID: 28152379
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral Vectors Pseudotyped with Filoviral Glycoproteins.
Sinn PL; Coffin JE; Ayithan N; Holt KH; Maury W
Methods Mol Biol; 2017; 1628():65-78. PubMed ID: 28573611
[TBL] [Abstract][Full Text] [Related]
18. Enhanced central nervous system transduction with lentiviral vectors pseudotyped with RVG/HIV-1gp41 chimeric envelope glycoproteins.
Trabalza A; Eleftheriadou I; Sgourou A; Liao TY; Patsali P; Lee H; Mazarakis ND
J Virol; 2014 Mar; 88(5):2877-90. PubMed ID: 24371049
[TBL] [Abstract][Full Text] [Related]
19. Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins.
Miletic H; Fischer YH; Neumann H; Hans V; Stenzel W; Giroglou T; Hermann M; Deckert M; Von Laer D
Hum Gene Ther; 2004 Nov; 15(11):1091-100. PubMed ID: 15610609
[TBL] [Abstract][Full Text] [Related]
20. Altering Entry Site Preference of Lentiviral Vectors into Neuronal Cells by Pseudotyping with Envelope Glycoproteins.
Kobayashi K; Kato S; Inoue K; Takada M; Kobayashi K
Methods Mol Biol; 2016; 1382():175-86. PubMed ID: 26611586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
